FDA - Food and Drug Administration

Cellular Intelligence strikes deal with Novo Nordisk to advance Parkinson’s cell therapy

'This cell therapy Parkinson's program is truly innovative and exemplifies the powerful convergence of exciting academic discovery with the uncompromising quality of a global pharmaceutical leader.'

In this photo illustration, a smartphone displays the logo of Novo Nordisk (NYSE: NVO), a Denmark-based pharmaceutical company specializing in diabetes care, obesity treatment, in front of a screen showing the company's latest stock market chart, January 29, 2026
US HEALTH and Human Services Secretary Robert F. Kennedy Jr.

RFK Jr.’s health department ordered withdrawal of studies showing vaccine efficiency - report

A person cups their hand to their ear in an act of listening (illustrative)

'Miracle cure': 2-year-old steals show at White House announcement of hearing loss therapy approval

 U.S. President Donald Trump signs an executive order encouraging more research into ibogaine, next to U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., Joe Rogan, and Americans for Ibogaine CEO W. Bryan Hubbard, in the Oval Office of the White House in Washington, D.C., April 18

Trump signs order to accelerate Ibogaine research for veterans with PTSD 


What other health conditions are weight-loss drugs being used and tested for?

Weight loss drugs like Ozempic and Wegovy can be used for a variety of other conditions, such as Alzheimer's, alcohol addiction, and liver disease.

 Boxes with the popular weight loss injection drug, Wegovy.

RFK Jr. discussed scaling back the role of FDA chief Makary, WSJ reports

"The White House maintains total confidence in the entire Health and Human Services and FDA team to deliver on President Trump’s pledge to Make America Healthy Again," a spokesperson told Reuters.

US PRESIDENT Donald Trump, as Health and Human Services Secretary Robert F. Kennedy Jr. looks on, makes an announcement linking autism to childhood vaccines and the use of Tylenol by pregnant women, in Washington, last week.

Remains of three hostages identified, Trump slams Ilhan Omar - November 3, 2025

The Jerusalem Post's must-listen news roundup with Shifra Jacobs—the top stories, clear and concise. 

US President Donald Trump and Israeli Prime Minister Benjamin Netanyahu at the Knesset on the day of Trump's address, amid a US-brokered prisoner-hostage swap and ceasefire deal between Israel and Hamas, in Jerusalem, October 13, 2025.

Israel's Pulsenmore gains FDA approval for at-home ultrasound device

Pulsenmore’s FDA-approved home ultrasound device allows pregnant women to perform scans from home, revolutionizing pregnancy care in remote areas.

The home ultrasound. Pregnancy monitoring even without going to the hospital

Maryland kosher pizzeria to furloughed federal workers: You can pay us back later

Ben Yehuda Pizza in Silver Spring is letting federal workers defer payments during the shutdown, inspiring others to donate meals in support.

Ben Yehuda Pizza in Silver Spring, Maryland.

FDA lifts ban on Juul's e-cigarette, authorizes US sales

The US Food and Drug Administration has authorized the sale of Juul's e-cigarette device and refill cartridges in tobacco and menthol flavors.

 Juul's e-cigarettes been banned in the US since 2022.

FDA approves Yeztugo: Gilead's new twice-yearly HIV prevention injection

Yeztugo has shown over 99% effectiveness in trials, surpassing daily PrEP pill Truvada.

 FDA approves Yeztugo: Gilead's new twice-yearly HIV prevention injection.

Could changes at the FDA call the kosher status of milk into question? Many are asking.

What happens if the federal government overhauls or abandons its oversight of milk?

 This type of cancer is 'getting younger'. Drinking a glass of milk daily may help.

A first in 25 years: FDA approves new type of painkiller

The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain management'.

 A first in 25 years: FDA approves new type of painkiller. Illustration.

FDA bans Red Dye No. 3 in food and ingested drugs due to cancer risk

The decision came after years of scrutiny and debate over the safety of Red No. 3, particularly concerning its potential impact on children and its alleged link to cancer.

 FDA bans Red Dye No. 3 in food and ingested drugs due to cancer risk. Illustration.